Singapore markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
86.81+0.64 (+0.74%)
At close: 04:00PM EDT
86.81 0.00 (0.00%)
After hours: 05:49PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
930,300
930,300
9,434,400
10,292,500
15,200
Depreciation & amortisation
183,400
183,400
123,300
75,200
38,700
Stock-based compensation
51,400
51,400
108,600
93,900
32,100
Change in working capital
5,574,800
5,574,800
4,518,500
-10,730,400
-93,100
Accounts receivable
-
-
4,369,900
-11,808,100
-247,900
Inventory
81,900
81,900
62,900
-438,400
-49,800
Accounts payable
118,900
118,900
85,700
1,516,100
204,600
Other working capital
4,665,900
4,665,900
13,214,100
735,700
-98,900
Other non-cash items
-1,275,500
-1,275,500
-297,900
199,100
114,400
Net cash provided by operating activities
5,371,400
5,371,400
13,577,400
889,700
-13,500
Cash flows from investing activities
Investments in property, plant and equipment
-705,500
-705,500
-363,300
-154,000
-85,400
Acquisitions, net
-336,900
-336,900
0
-20,800
-60,600
Purchases of investments
-7,128,400
-7,128,400
-47,800
-394,700
0
Sales/maturities of investments
1,216,300
1,216,300
375,200
-
-
Net cash used for investing activities
-6,954,500
-6,954,500
-35,300
-566,100
-144,800
Cash flows from financing activities
Debt repayment
-40,400
-40,400
-59,900
-66,700
-14,300
Common stock issued
0
0
110,500
160,900
753,000
Common stock repurchased
-738,500
-738,500
-986,400
0
0
Dividends paid
0
0
-484,300
0
0
Net cash used provided by (used for) financing activities
-778,600
-778,600
-1,419,300
94,200
894,700
Net change in cash
-2,361,700
-2,361,700
12,122,800
417,800
736,400
Cash at beginning of period
13,875,100
13,875,100
1,692,700
1,210,200
519,100
Cash at end of period
11,663,700
11,663,700
13,875,100
1,692,700
1,210,200
Free cash flow
Operating cash flow
5,371,400
5,371,400
13,577,400
889,700
-13,500
Capital expenditure
-705,500
-705,500
-363,300
-154,000
-85,400
Free cash flow
4,665,900
4,665,900
13,214,100
735,700
-98,900